Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

Cited by (967)

Items 101–200 of 967

1. Targeting STAT3 affects melanoma on multiple fronts
   Marcin Kortylewski, Richard Jove, Hua Yu · 2005 · Cancer and Metastasis Reviews
2. Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
   Gregg L. Semenza · 2001 · Pediatric Research
3. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
   Xia, Yan, Choi, Hyun-Kyung, Lee, Kyeong · 2012 · European Journal of Medicinal Chemistry
4. Role of hypoxia-inducible factors in breast cancer metastasis
   Gilkes, Daniele M, Semenza, Gregg L · 2013 · Future Oncology
5. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
   Gabi U. Dachs, Gillian M. Tozer · 2000 · European Journal of Cancer
6. Regulation of Angiogenesis by Hypoxia and Hypoxia‐Inducible Factors
   Michele M. Hickey, Marie Celeste Simon · 2006 · Current topics in developmental biology/Current Topics in Developmental Biology
7. Reciprocal influence of the p53 and the hypoxic pathways
   Audrey Sermeus, Carine Michiels · 2011 · Cell Death and Disease
8. Emerging avenues linking inflammation and cancer
   Joydeb Kumar Kundu, Young‐Joon Surh · 2012 · Free Radical Biology and Medicine
9. Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients
   Jean-Philippe Dalès, Stéphane Garcia, Séverine Meunier-Carpentier, L Andrac, Olivier Haddad, Marie‐Noëlle Lavaut, Claude Allasia, Pascal Bonnier, Colette Charpin · 2005 · International Journal of Cancer
10. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
    Jose G. Teodoro, Sara K. Evans, Michael R. Green · 2007 · Journal of Molecular Medicine
11. Histone Deacetylase Inhibitors Induce VHL and Ubiquitin-Independent Proteasomal Degradation of Hypoxia-Inducible Factor 1α
    Kong, Xianguo, Lin, Zhao, Liang, Dongming, Fath, Donna, Sang, Nianli, Caro, Jaime · 2006 · Molecular and Cellular Biology
12. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
    Mans Broekgaarden, Ruud Weijer, Thomas M. van Gulik, Michael Richard Hamblin, Michal Heger · 2015 · Cancer and Metastasis Reviews
13. Is HIF-1α a pro- or an anti-apoptotic protein?
    Jean‐Pascal Piret, Denis Mottet, Martine J. Raes, Carine Michiels · 2002 · Biochemical Pharmacology
14. Revisiting the HIF switch in the tumor and its immune microenvironment.
    Cowman, Sophie J., Koh, Mei Yee · 2022 · Trends in Cancer
15. HIF-1: Using Two Hands to Flip the Angiogenic Switch
    Gregg L. Semenza · 2000 · Cancer and Metastasis Reviews
16. VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail
    Andrew John Evans, Ryan Charles Russell, Olga Roche, T Nadine Burry, Jason E. Fish, Vinca W. K. Chow, William Y. Kim, Arthy Saravanan, Mindy A. Maynard, Michelle L. Gervais et al. · 2006 · Molecular and Cellular Biology
17. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors
    Zimmer, Michael, Doucette, Darrell, Siddiqui, Naila, Iliopoulos, Othon · 2004 · Molecular Cancer Research
18. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α
    Welsh, Sarah, Williams, Ryan, Kirkpatrick, Lynn, Paine-Murrieta, Gillian, Powis, Garth · 2004 · Molecular Cancer Therapeutics
19. Microenvironmental and cellular consequences of altered blood flow in tumours
    Natarajan Raghunand, Robert A. Gatenby, Robert J. Gillies · 2003 · British Journal of Radiology
20. The oncofetal H19 RNA connection: Hypoxia, p53 and cancer
    Imad Matouk, Shaul Mezan, Aya Mizrahi, Patricia Ohana, Rasha Abu-lail, Yakov Fellig, Nathan de-Groot, Eithan Galun, Abraham Hochberg · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
21. Mitochondria in Vascular Health and Disease
    Peter Dromparis, Evangelos D. Michelakis · 2012 · Annual Review of Physiology
22. Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
    Kim, William Y, Safran, Michal, Buckley, Marshall RM, Ebert, Benjamin L, Glickman, Jonathan, Bosenberg, Marcus, Regan, Meredith, Kaelin, William G · 2006 · The EMBO Journal
23. DUBs, Hypoxia, and Cancer
    Daniela Mennerich, Kateryna I. Kubaichuk, Thomas Kietzmann · 2019 · Trends in cancer
24. Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches
    Harman Talat Saman, Syed Shadab Raza, Shahab Uddin M.S., Kakil Ibrahim Rasul · 2020 · Cancers
25. Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
    Iommarini, Luisa, Porcelli, Anna Maria, Gasparre, Giuseppe, Kurelac, Ivana · 2017 · Frontiers in Oncology
26. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
    Jinmei Jin, Shuiping Qiu, Ping Wang, Xiaohui Liang, Fei Huang, Hui Wu, Beibei Zhang, Weidong Zhang, Xin-Hui Tian, Ren Xu et al. · 2019 · Journal of Experimental & Clinical Cancer Research
27. Dephosphorylated hypoxia-inducible factor 1α as a mediator of p53-dependent apoptosis during hypoxia
    Hiroyuki Suzuki, Akihiro Tomida, Takashi Tsuruo · 2001 · Oncogene
28. MAP Kinases and Hypoxia in the Control of VEGF Expression
    Edurne Berra, Gilles Pagès, Jacques Pouysségur · 2000 · Cancer and Metastasis Reviews
29. Novel approaches in the therapy of metastatic renal cell carcinoma
    John S. Lam, John T. Leppert, Arie S. Belldegrun, Robert A. Figlin · 2005 · World Journal of Urology
30. Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor Growth
    Janusz W. Rak, Joanne Yu, Giannoula Lakka Klement, Robert S. Kerbel · 2000 · Journal of Investigative Dermatology Symposium Proceedings
31. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
    Omar López-Ocejo, Alicia Viloria‐Petit, Mónica Béquet‐Romero, Debabrata Mukhopadhyay, Janusz W. Rak, Robert S. Kerbel · 2000 · Oncogene
32. Blood Pressure and Risk of Renal Cell Carcinoma in the European Prospective Investigation into Cancer and Nutrition
    S. Weikert, Heiner Boeing, Tobias Pischon, Cornelia Weikert, Anja Olsen, Anne Marie Tjønneland, Kim Overvad, Nikolaus Becker, Jakob Linseisen, Antonia Trichopoulou et al. · 2007 · American Journal of Epidemiology
33. Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
    Yoshihiro Hayashi, Asumi Yokota, Hironori Harada, Gang Huang · 2019 · Cancer Science
34. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses
    Sophie Vasseur, Samia Afzal, J. Tardivel‐Lacombe, David S. Park, Juan Iovanna, Tak W. Mak · 2009 · Proceedings of the National Academy of Sciences
35. Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications
    Christiane Brahimi‐Horn, Nathalie M. Mazure, Jacques Pouysségur · 2004 · Cellular Signalling
36. Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors
    Olga N. Aprelikova, Gadisetti V.R. Chandramouli, Matthew J. A. Wood, James Robert Vasselli, Joseph Riss, Jodi Kathleen Maranchie, William Marston Linehan, J. Carl Barrett · 2004 · Journal of Cellular Biochemistry
37. Targeting the hypoxia-inducible factor (HIF) pathway in cancer
    Evon Poon, Adrian Llewellyn Harris, Margaret A. Ashcroft · 2009 · Expert Reviews in Molecular Medicine
38. Dichloroacetate and cancer: New home for an orphan drug?
    Shyam Kankotia, Peter W. Stacpoole · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
39. Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
    Yunho Kim, Hye Jin Nam, Junyeop Lee, Do Young Park, Chan Kim, Young Suk Yu, Dongha Kim, Se Won Park, Jinhyuk Bhin, Daehee Hwang et al. · 2016 · Nature Communications
40. Comparative Expression Profiling in Pulmonary Fibrosis Suggests a Role of Hypoxia-inducible Factor-1α in Disease Pathogenesis
    Αrgyris Τzouvelekis, Vaggelis Harokopos, Triantafyllos Paparountas, Nikos Oikonomou, Aristotelis A. Chatziioannou, George Vilaras, Evangelos Tsiambas, Andreas Karameris, Demosthenes E. Bouros, Vassilis Aidinis · 2007 · American Journal of Respiratory and Critical Care Medicine
41. Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
    Young Chan Chae, Valentina Vaira, M. Cecilia Caino, Hsin‐Yao Tang, Jae Ho Seo, Andrew V. Kossenkov, Luisa Ottobrini, Cristina Martelli, Giovanni Lucignani, Irene Bertolini et al. · 2016 · Cancer Cell
42. Reactive oxygen species and HIF-1 signalling in cancer
    Αlex Galanis, Aglaia Pappa, Antonis Giannakakis, Evripidis Lanitis, Denarda Dangaj Laniti, Raphael Sandaltzopoulos · 2008 · Cancer Letters
43. Natural mechanisms protecting against cancer
    Marek Jakóbisiak, Witold Lasek, Jakub Gołąb · 2003 · Immunology Letters
44. Hypoxia‐inducible factor‐1 and oncogenic signalling
    Julia I. Bárdos, Margaret A. Ashcroft · 2004 · BioEssays
45. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension
    Gopinath Sutendra, Peter Dromparis, Roxane Paulin, Sotirios D. Zervopoulos, Alois Haromy, Jayan Nagendran, Evangelos D. Michelakis · 2013 · Journal of Molecular Medicine
46. TP53: a key gene in human cancer
    Denise Peixoto Guimarães, Pierre L. Hainaut · 2002 · Biochimie
47. MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis
    Cha, Shih-Ting, Chen, Pai-Sheng, Johansson, Gunnar, Chu, Chia-Yu, Wang, Ming-Yang, Jeng, Yung-Ming, Yu, Sung-Liang, Chen, Jin-Shing, Chang, King-Jen, Jee, Shiou-Hwa et al. · 2010 · Cancer Research
48. p53 Signaling and Cell Cycle Checkpoints
    Zoe A. Stewart, Jennifer A. Pietenpol · 2001 · Chemical Research in Toxicology
49. Redox sensor CtBP mediates hypoxia-induced tumor cell migration
    Qinghong Zhang, Su-Yan Wang, Amanda C. Nottke, Jonathan V. Rocheleau, David W. Piston, Richard H. Goodman · 2006 · Proceedings of the National Academy of Sciences
50. Mechanisms of adaptive angiogenesis to tissue hypoxia
    Guo‐Hua Fong · 2008 · Angiogenesis
51. The essential role of Cited2, a negative regulator for HIF-1α, in heart development and neurulation
    Zhan Yin, J. Marshall Haynie, Xiaoming Yang, Baoguang Han, Songsak Kiatchoosakun, Joseph Restivo, Saying Yuan, Nanduri R. Prabhakar, Karl Herrup, Ronald A. Conlon et al. · 2002 · Proceedings of the National Academy of Sciences
52. Jab1 interacts directly with HIF-1α and regulates its stability
    Bae, Moon-Kyoung, Ahn, Mee-Young, Jeong, Joo-Won, Bae, Myung-Ho, Lee, You Mie, Bae, Soo-Kyung, Park, Jong-Wan, Kim, Kwang-Rok, Kim, Kyu-Won · 2002 · Journal of Biological Chemistry
53. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
    Edurne Berra, Julie Milanini, Darren E. Richard, Maude Le Gall, Francesc Viñals, Emmanuel Gothié, Danièle Roux, Gilles Pagès, Jacques Pouysségur · 2000 · Biochemical Pharmacology
54. Angiogenesis in prostate cancer: onset, progression and imaging
    Giovanna Russo, Massimo Mischi, Wout A. Scheepens, Jean J.M.C.H. de la Rosette, Hessel Wijkstra · 2012 · British Journal of Urology
55. p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase
    Jose G. Teodoro, Albert E. Parker, Xiaochun Zhu, Michael R. Green · 2006 · Science
56. Human HIF‐3α4 is a dominant‐negative regulator of HIF‐1 and is down‐regulated in renal cell carcinoma
    Mindy A. Maynard, Andrew John Evans, Tomoko Hosomi, Shuntaro Hara, Michael A.S. Jewett, Michael Ohh · 2005 · The FASEB Journal
57. EC5S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors
    Qiliang Cai, Jason S. Knight, Suhbash C. Verma, Philip B. Zald, Erle S. Robertson · 2006 · PLoS Pathogens
58. HIF‐1 and p53: communication of transcription factors under hypoxia
    Tobias Schmid, Jie Zhou, Bernhard Brüne · 2004 · Journal of Cellular and Molecular Medicine
59. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer
    Gopinath Sutendra, Peter Dromparis, Adam S. Kinnaird, Trevor H. Stenson, Alois Haromy, J. M. R. Parker, Michael Sean McMurtry, Evangelos D. Michelakis · 2012 · Oncogene
60. HIFs and tumors—causes and consequences
    Gisele Höpfl, Omolara O. Ogunshola, Max Gassmann · 2004 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
61. Hypoxia‐inducible factor‐1α (HIF‐1α) escapes O2‐driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm
    Edurne Berra, Danièle Roux, Darren E. Richard, Jacques Pouysségur · 2001 · EMBO Reports
62. Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
    Rajinikanth Gogiraju, Magdalena L. Bochenek, Katrin Schäfer · 2019 · Frontiers in Cardiovascular Medicine
63. Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation
    Mei Yee Koh, Bryant G. Darnay, Garth Powis · 2008 · Molecular and Cellular Biology
64. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation
    Patrick A. Carroll, Elizabeth Brazeau, Michael Lagunoff · 2004 · Virology
65. Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation
    Emmanuel Minet, Gaëtan Michel, Denis Mottet, Martine J. Raes, Carine Michiels · 2001 · Free Radical Biology and Medicine
66. Hepatitis B Virus X Protein Enhances Transcriptional Activity of Hypoxia-inducible Factor-1α through Activation of Mitogen-activated Protein Kinase Pathway
    Young‐Gun Yoo, Seung Hyun Oh, Eun Sook Park, Hyeseong Cho, Naery Lee, Hyunsung Park, Dae Kyong Kim, Dae‐Yeul Yu, Je Kyung Seong, Mi‐Ock Lee · 2003 · Journal of Biological Chemistry
67. The role of hypoxia in inflammatory disease (Review)
    John Biddlestone, Daniel Bandarra, Sónia Rocha · 2015 · International Journal of Molecular Medicine
68. Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
    Ivana Jochmanová, Chunzhang Yang, Zhengping Zhuang, Karel Pacák · 2013 · JNCI Journal of the National Cancer Institute
69. Genotoxic and non-genotoxic pathways of p53 induction
    Olivier Pluquet, Pierre L. Hainaut · 2001 · Cancer Letters
70. Redox regulation of p53 during hypoxia
    Navdeep S. Chandel, Matthew G. Vander Heiden, Craig B. Thompson, Paul T. Schumacker · 2000 · Oncogene
71. Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
    Davinder Pal Singh, Rohit Arora, Pardeep Kaur, Balbir Singh, Rahul Mannan, Saroj Arora · 2017 · Cell & Bioscience
72. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 ( Arnt2 ) gene reveals partial redundancy with Arnt
    Brian Keith, David Matthew Adelman, Marie Celeste Simon · 2001 · Proceedings of the National Academy of Sciences
73. Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
    Peter A. Kreuzaler, Yulia Panina, Joanna Segal, Mariia O. Yuneva · 2019 · Molecular Metabolism
74. Constitutive and inducible expression and regulation of vascular endothelial growth factor
    Keping Xie, Daoyan Wei, Qian Shi, Suyun Huang · 2004 · Cytokine & Growth Factor Reviews
75. Human Papillomavirus E7 Enhances Hypoxia-Inducible Factor 1–Mediated Transcription by Inhibiting Binding of Histone Deacetylases
    Jason M. Bodily, Kavi P.M. Mehta, Laimonis A. Laimins · 2010 · Cancer Research
76. The anaemia of cancer: death by a thousand cuts
    Jerry L. Spivak · 2005 · Nature reviews. Cancer
77. HIF‐1α and HIF‐2α have divergent roles in colon cancer
    Takaaki Imamura, Hirotoshi Kikuchi, Maite Herráiz, Do‐Youn Park, Yusuke Mizukami, Mari A. Mino-Kenudson, Maureen P. Lynch, Bo R. Rueda, Yair Benita, Ramnik J. Xavier et al. · 2008 · International Journal of Cancer
78. New anticancer strategies targeting HIF-1
    Eun-Jin Yeo, Yang‐Sook Chun, Jong‐Wan Park · 2004 · Biochemical Pharmacology
79. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke
    Rachel E. Speer, Saravanan S. Karuppagounder, Manuela Basso, Sama F. Sleiman, Amit Kumar, David Brand, Natalya Smirnova, Irina G. Gazaryan, Soah J. Khim, Rajiv R. Ratan · 2013 · Free Radical Biology and Medicine
80. Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
    Kotaro Miyake, Tomoharu Yoshizumi, Satoru Imura, Koji Sugimoto, Erdenebulgan Batmunkh, Hirofumi Kanemura, Yuji Morine, Mitsuo Shimada · 2008 · Pancreas
81. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis
    Mei‐Tsz Su, Sheng‐Hsiang Lin, Yi‐Chi Chen · 2011 · Human Reproduction Update
82. HIF-1: master and commander of the hypoxic world
    Nathalie M. Mazure, M. Christiane Brahimi-Horn, Mélanie Berta, Emmanuel Isaac Benizri, Rebecca L. Bilton, Frédéric Dayan, Amandine Ginouvès, Edurne Berra, Jacques Pouysségur · 2004 · Biochemical Pharmacology
83. Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
    Yamamoto, Yutaka, Ibusuki, Mutsuko, Okumura, Yasuhiro, Kawasoe, Teru, Kai, Kazuharu, Iyama, Kenichi, Iwase, Hirotaka · 2008 · Breast Cancer Research and Treatment
84. Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma
    Zhang, Lin, Yang, Nuo, Conejo Garcia, Jose-Ramon, Mohamed, Alisha, Benencia, Fabian, Rubin, Stephen C., Allman, David, Coukos, George · 2002 · The American Journal of Pathology
85. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
    Ivano Amelio, Gerry Melino · 2015 · Trends in Biochemical Sciences
86. The VHL tumor suppressor and HIF: insights from genetic studies in mice
    Kapitsinou, P P, Haase, V H · 2008 · Cell Death & Differentiation
87. Genetic and hypoxic regulation of angiogenesis in gliomas
    Balveen Kaur, Chalet Tan, Daniel Jay Brat, Erwin G. Van Meir · 2004 · Journal of Neuro-Oncology
88. Increase of SUMO-1 expression in response to hypoxia: Direct interaction with HIF-1α in adult mouse brain and heart in vivo
    Shao, Ruijin, Zhang, Fu-Ping, Tian, Fei, Anders Friberg, P, Wang, Xiaoyang, Sjöland, Helen, Billig, Håkan · 2004 · FEBS Letters
89. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line
    Lee, Kyeong, Kang, Jung Eun, Park, Song-Kyu, Jin, Yinglan, Chung, Kyung-Sook, Kim, Hwan-Mook, Lee, Kiho, Kang, Moo Rim, Lee, Myung Kyu, Song, Kyung Bin et al. · 2010 · Biochemical Pharmacology
90. HIF‐1‐dependent transcriptional activity is required for oxygen‐mediated HIF‐1α degradation
    Edurne Berra, Darren E. Richard, Emmanuel Gothié, Jacques Pouysségur · 2001 · FEBS Letters
91. Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis
    Bradley McColl, Steven A. Stacker, Marc G. Achen · 2004 · Apmis
92. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
    Esra Toussaint, David B. Donner, Ann Roman · 2004 · Oncogene
93. Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues
    Fabrice Rossignol, Christel Vaché, Eric Clottes · 2002 · Gene
94. P53: An ubiquitous target of anticancer drugs
    Mikhail V. Blagosklonny · 2001 · International Journal of Cancer
95. Hypoxia‐inducible factor 1 and cancer pathogenesis
    Gregg L. Semenza · 2008 · IUBMB Life
96. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
    Mingjian James You, Diego H. Castrillón, Boris C. Bastian, Rónán C. O’Hagan, Marcus Bosenberg, Ramon E. Parsons, Lynda Chin, Ronald Anthony DePinho · 2002 · Proceedings of the National Academy of Sciences
97. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells
    Neil T. Pfister, Vitalay Fomin, Kausik Regunath, Jeffrey Y. Zhou, Wen Zhou, Laxmi Silwal‐Pandit, William A. Freed-Pastor, Oleg Laptenko, Suat Peng Neo, Jill Bargonetti et al. · 2015 · Genes & Development
98. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma
    Jean-François H. Geschwind, Christos S. Georgiades, Young Hee Ko, Peter L. Pedersen · 2004 · Expert Review of Anticancer Therapy
99. Regulation of angiogenesis by oxygen sensing mechanisms
    Guo‐Hua Fong · 2009 · Journal of Molecular Medicine
100. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
     Ivano Amelio, Mara Mancini, Varvara Petrova, Rob A. Cairns, П. Н. Вихрева, Sara Nicolai, Alberto Marini, Alexey A. Antonov, John P. C. Le Quesne, Juvenal Dario Baena Acevedo et al. · 2018 · Proceedings of the National Academy of Sciences